Binding affinities of selected compounds 1c, 2c, 3f, and 3h with essential residues into the active site of PTR1–Leishmania protein and DHFR–TS/T. cruzi.
Entries | Compd. | Energies in binding sites (kcal mol−1) | H-interactiona | ||||
---|---|---|---|---|---|---|---|
PTR1–Leishmania | DHFR–TS–T.cruzi | ||||||
MTX 1292b | MTX 301c | C601d | C1029e | MTX 1292 | C1029 | ||
1 | MTX | −8.87 | −7.85 | −9.11 | −9.54 | Tyr-455 (2.85 Å), Tyr-452 (2.67 Å), Ser-385 (2.64 Å) | Asp-561 (2.83 Å), Ile-667 (2.70 Å) |
2 | 1c | −10.13 | −8.44 | −10.18 | −10.65 | No hydrogen bonding | Arg-566 (two bindings at 2.87 Å; 2.72 Å) |
3 | 2c | −10.16 | −8.93 | −10.33 | −11.14 | Arg-300 (2.79 Å) | Arg-566 (two bindings: 2.30 Å; 2.78 Å), Phe-601 (2.99 Å) |
4 | 3f | −8.87 | −8.79 | −11.24 | −10.09 | No hydrogen bonding | Arg-566 (2.42 Å), Ser-553 (2.90 Å) |
5 | 3h | −9.01 | −8.89 | −10.33 | −10.06 | Tyr-452 (2.99 Å), Tyr-452 (2.25 Å) | Arg-566 (2.41 Å), Ser-533 (2.90 Å) |
Hydrogen bond interactions.
Binding site in cavity 1 for methotrexate.
Binding site in cavity 2 for methotrexate.
Binding site in cavity 1 for antifolate C50 and.
Binding site in cavity 2 for antifolate C50.